Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Our committees
Who we are
What we do
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Accessing medicines
›
One Wales Medicines process
›
One Wales medicine assessment documents
›
OW01 documents
OW01 documents
11/04/2024
Original reassessment: Bevacizumab (OW01) One Wales Interim Decision and rationale Jul 19
11/04/2024
Original reassessment: Bevacizumab (OW01) Evidence Status Report July 2019
11/04/2024
First review: Bevacizumab (OW01) One Wales Interim Decision and review report Sep 20
11/04/2024
Second review: Bevacizumab (OW01) One Wales Interim Decision and review report Sep 21
11/04/2024
Third review: Bevacizumab (OW01) One Wales Interim Decision and review report Dec 22
11/04/2024
Fourth review: Bevacizumab (OW01) One Wales Interim Decision and review report Feb 24
Follow AWTTC:
